News
UNC, Duke doctors sound off on RFK Jr.’s claims about mRNA vaccines
CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an email to The N&O, a company spokesperson said its mRNA programs cited by HHS aren’t active and thus “this decision has no impact on our research.”
1don MSN
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
The settlement ends US mRNA patent disputes involving COVID-19 and influenza vaccines, while positioning GSK for additional ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...
HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...
On Tuesday, the US Department of Health and Human Services disclosed the end of funding for 22 mRNA vaccine projects — a ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback